Suvretta Capital Management’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
Suvretta Capital Management's KURA Position: Q3 2026 in Review
Suvretta Capital Management reduced its Kura Oncology (KURA) stake by 7.9% in Q3 2026, selling an estimated $7.55M and leaving 7,900,000 shares worth $84.6M. The position accounts for 1.97% of the portfolio, ranked #16.
Suvretta Capital Management first reported a position in KURA in Q3 2020 and has held it in 25 quarters since. The position peaked at $151M in Q1 2024. 233 funds tracked by Wall St. Rank hold KURA as of Q3 2026.
- Suvretta Capital Management held 7,900,000 shares of Kura Oncology worth $84.6M as of Q3 2026.
- Suvretta Capital Management sold 675,422 Kura Oncology shares in Q3 2026, an estimated $7.55M.
- Kura Oncology made up 1.97% of Suvretta Capital Management's portfolio in Q3 2026, its #16 holding.
- Suvretta Capital Management first reported a position in Kura Oncology in Q3 2020 and has held it in 25 quarters since.
- Suvretta Capital Management's Kura Oncology position peaked at $151M in Q1 2024.
- 233 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.
Based on Suvretta Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.